tailieunhanh - báo cáo hóa học:" The "Excellence in Translational Medicine" and "Bedside-to-Bench" Awards 2007–08"

Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí sinh học quốc tế đề tài : The "Excellence in Translational Medicine" and "Bedside-to-Bench" Awards 2007–08 | Journal of Translational Medicine BioMed Central Open Access The Excellence in Translational Medicine and Bedside-to-Bench Awards 2007-08 Richard J Ablin 1 Francesco M Marincola2 and Pier Giorgio Natali3 Address Departments of Immunobiology and Pathology University of Arizona College of Medicine Arizona Cancer Center and BIO5 Institute Tucson AZ 85724 USA infectious Disease and Immunogenetics Section IDIS Department of Transfusion Medicine Clinical Center National Institutes of Health Bethesda MD 20892 USA and 3Immunology and Molecular Pathology Laboratories Regina Elena National Cancer Institute Rome Italy Email Richard J Ablin - ablinrj@ Francesco M Marincola - fmarincola@ Pier Giorgio Natali - natalipg2002@ Corresponding author Published 9 July 2009 Received 7 June 2009 Journal of Translational Medicine 2009 7 57 doi 1479-5876-7-57 Accepted 9 July 2009 This article is available from http content 7 1 57 2009 Ablin et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Editorial In a continuing endeavor to recognize outstanding contributions in the field of translational medicine the Editorial Board of the Journal of Translational Medicine JTM established The Excellence in Translational Medicine Award in 2006 1 . With the thought to also recognize excellent studies defined as those exclusively based on the study of human subjects the Editorial Board has further established The Bedside-to-Bench Award in 2008 2 . The recipient of The Excellence in Translational Medicine Award will receive a 4 000 prize of which 1 500 is sponsored by Pfizer Global Research and Development and Global Translational Medicine and 2 500 contributed anonymously . The .